There’s been a “lot of talk about digital therapeutics within the consumer health industry,” with the excitement around this space “growing rapidly,” according to Bayer’s David Evendon-Challis.
“When there’s an opportunity for digital to not just be a health companion, which is useful in many instances, but actually to provide a service directly, that is really interesting
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?